Circulating tumor cells in patients with colorectal liver metastasis predict impaired survival

Annals of Surgery

Volumn 261, Issue 1, 2015, Pages 164-171

  Seeberg, Lars Thomas ^a,b   Waage, Anne ^a   Brunborg, Cathrine ^a   Hugenschmidt, Harald ^a   Renolen, Anne ^a   Stav, Ingun ^a   Bjørnbeth, Bjørn Atle ^a   Brudvik, Kristoffer W ^a   Borgen, Elin F ^a   Naume, Bjørn ^a,c   Wiedswang, Gro ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b VESTFOLD HOSPITAL TRUST   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Circulating tumor cells; Colorectal cancer; Disseminated tumor cells; Liver metastasis; Micrometastases

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CIRCULATING TUMOR CELL; COLORECTAL LIVER METASTASIS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SURVIVAL PREDICTION; VERY ELDERLY; BONE MARROW CANCER; COLORECTAL TUMOR; DISEASE COURSE; LIVER NEOPLASMS; MORTALITY; PATHOLOGY; PROGNOSIS; RISK FACTOR; SECONDARY; TUMOR EMBOLISM; TUMOR RECURRENCE;

BONE MARROW NEOPLASMS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HUMANS; LIVER NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; RISK FACTORS;

EID: 84926323606     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000580     Document Type: Article

References (28)

1. Ferlay J, Shin H, Bray F, et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide, IARC CancerBase. Lyon, France: International Agency for Research on Cancer; 2010.
2. Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006; 244: 254-259.
3. Alberts SR, Poston GJ. Treatment advances in liver-limited metastatic colorectal cancer. Clin Colorectal Cancer. 2011; 10: 258-265.
4. Gallagher DJ, Kemeny N. Improving response and outcomes for patients with liver-limited metastatic colorectal cancer. Clin Colorectal Cancer. 2010; 9(suppl 1): S36-S43.
5. Rees M, Tekkis PP, Welsh FK, et al. Evaluation of long-time survival after hepatic resection for metastatic colorectal cancer. Ann Surg. 2008; 247: 125-135.
6. Reissfelder C, Rhabbari NN, Koch M, et al. Validation of prognostic scoring systems for patients undergoing resection of colorectal liver metastases. Ann Surg Onc. 2009; 16: 3279-3288.
7. Pantel K, Alix-Panabières C, Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol. 2009; 6: 339-351.
8. Cohen SJ, Punt CJ, Ianotti N, et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol. 2009; 20: 1223-1229.
9. Allen JE, El-Deiry WS. Circulating tumour cells and colorectal cancer. Curr Colorectal Ca Rep. 2010; 6: 212-220.
10. Tol J, Koopman M, Miller MC, et al. Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. Ann Oncol. 2010; 21: 1006-1012.
11. Rhabari NN, Aigner M, Thorlund K, et al. Meta-analyses shows that detection of circulating tumour cells indicate poor prognosis in patients with colorectal cancer. Gastroenterology. 2010; 138: 1714-1726.
12. Koerkamp BG, Rahbari NN, Buchler MW, et al. Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: a meta-analysis. Ann Surg Oncol. 2013; 20: 2156-2165.
13. Adam R, De Gramont A, Figueras J, et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist. 2012; 17: 1225-1239.
14. Van Cutsem E, Nordlinger B, Adam R, et al. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer. 2006; 42: 2212-2221.
15. Wiedswang G, Borgen E, Karesen R, et al. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol. 2003; 21: 3469-3478.
16. Borgen E, Naume B, Nesland JM, et al. Use of automated microscopy for the detection of disseminated tumor cells in bone marrow samples. Cytometry. 2001; 46: 215-221.
17. Borgen E, Naume B, Nesland JM, et al. Standardization of the immunocytochemical detection of cancer cells in BM and blood: I-Establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy. 1999; 1: 377-388.
18. Riethdorf S, Fritsche H, Müller V, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res. 2007; 13: 920-928.
19. Cohen SJ, Punt CJA, Iannotti N, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. JCO. 2008; 26: 3213-3221.
20. Papavasiliou P, Fisher T, Kuhn J, et al. Circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. Baylor Univ Med Cent Pro. 2010; 23: 11-14.
21. Cristofanelli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl JMed. 2004; 35: 781-791.
22. Bidard F-C, Pierga J-Y, Soria J-C, et al.Translatingmetastasis-related biomarkers to the clinic-progress and pitfalls. Nat Rev Clin Onc. 2013; 10: 169-179.
23. Flatmark K, Borgen E, Nesland JM, et al. Disseminated tumour cells as a prognostic marker in colorectal cancer. Br J Cancer. 2011; 104: 1434-1439.
24. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011; 331: 1559-1564.
25. Georges TM, Pantel K. Circulating tumour cells as therapy-related biomarkers in cancer patients. Cancer Immunol Immunother. 2013; 62: 931-939.
26. de Jong MC, Mayo SC, Pulitano C, et al. Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis. J Gastrointest Surg. 2009; 13: 2141-2151.
27. Synnestvedt M, Borgen E, Wist E, et al. Disseminated tumor cells as selection marker and monitoring tool for sec adjuvant treatment in early breast cancer. Descriptive results from an intervention study. BMC Cancer. In press.
28. Gazzaniga P, Raimondi C, Gradilone A, et al. Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff? J Cancer Res Clin Oncol. 2013; 139: 1411-1416.